115 related articles for article (PubMed ID: 3495005)
41. Phenotypic characterization of individual interferon-gamma-producing cells after OKT3 antibody activation.
Andersson U; Laskay T; Andersson J; Kiessling R; DeLey M
Eur J Immunol; 1986 Nov; 16(11):1457-60. PubMed ID: 3096747
[TBL] [Abstract][Full Text] [Related]
42. Clonal analysis of the involvement of T11 molecules in antigen receptor-mediated T lymphocyte functions.
Moretta A; Pantaleo G; Lopez-Botet M; Carrel S; Moretta L
Behring Inst Mitt; 1985 Aug; (77):39-47. PubMed ID: 2417584
[TBL] [Abstract][Full Text] [Related]
43. Monocyte-regulated hyporesponsiveness of human cord blood lymphocytes to OKT3-monoclonal-antibody-induced mitogenesis.
Papadogiannakis N; Johnsen SA; Olding LB
Scand J Immunol; 1986 Jan; 23(1):91-9. PubMed ID: 3085209
[TBL] [Abstract][Full Text] [Related]
44. Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens.
Lanier LL; Benike CJ; Phillips JH; Engleman EG
J Immunol; 1985 Feb; 134(2):794-801. PubMed ID: 3871216
[TBL] [Abstract][Full Text] [Related]
45. Role of interleukin 2 receptor beta chain in initiating anti-CD3 and interleukin 2-induced proliferation of human resting T cells.
Moiré N; Calvo CF; Métivier D; Perrot JY; Vaquero C; Hatakeyama M; Senik A
Eur J Immunol; 1990 Sep; 20(9):1981-7. PubMed ID: 2145171
[TBL] [Abstract][Full Text] [Related]
46. A monoclonal antibody reactive with a 15-kDa cytoplasmic granule-associated protein defines a subpopulation of CD8+ T lymphocytes.
Anderson P; Nagler-Anderson C; O'Brien C; Levine H; Watkins S; Slayter HS; Blue ML; Schlossman SF
J Immunol; 1990 Jan; 144(2):574-82. PubMed ID: 2104899
[TBL] [Abstract][Full Text] [Related]
47. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
Vujanovic NL; Herberman RB; Olszowy MW; Cramer DV; Salup RR; Reynolds CW; Hiserodt JC
Cancer Res; 1988 Feb; 48(4):884-90. PubMed ID: 3257412
[TBL] [Abstract][Full Text] [Related]
48. Selective inhibition of human T cell cytotoxicity at levels of target recognition or initiation of lysis by monoclonal OKT3 and Leu-2a antibodies.
Landegren U; Ramstedt U; Axberg I; Ullberg M; Jondal M; Wigzell H
J Exp Med; 1982 May; 155(5):1579-84. PubMed ID: 6978378
[TBL] [Abstract][Full Text] [Related]
49. The effect of anti-CD3 on the induction of non-MHC restricted cytolytic activity.
Watanabe H; Narumi K; Stewart CC; Arbuck SG; Foon KA; Goldrosen MH
Anticancer Res; 1992; 12(6B):1925-33. PubMed ID: 1295440
[TBL] [Abstract][Full Text] [Related]
50. Lymphocytes infiltrating human ovarian tumors. I. Role of Leu-19 (NKH1)-positive recombinant IL-2-activated cultures of lymphocytes infiltrating human ovarian tumors.
Heo DS; Whiteside TL; Kanbour A; Herberman RB
J Immunol; 1988 Jun; 140(11):4042-9. PubMed ID: 3286766
[TBL] [Abstract][Full Text] [Related]
51. Evidence for IL-2 independent proliferation in human T cells.
Laing TJ; Weiss A
J Immunol; 1988 Feb; 140(4):1056-62. PubMed ID: 2830333
[TBL] [Abstract][Full Text] [Related]
52. Phenotypic and cell cycle analysis of human peripheral blood mononuclear cells activated with interleukin-2 and/or OKT3.
Platts KE; Lawry J; Hancock BW; Rees RC
Exp Cell Res; 1993 Sep; 208(1):154-60. PubMed ID: 8359215
[TBL] [Abstract][Full Text] [Related]
53. Cytolytic activity of human peripheral blood leukocytes against Legionella pneumophila-infected monocytes: characterization of the effector cell and augmentation by interleukin 2.
Blanchard DK; Stewart WE; Klein TW; Friedman H; Djeu JY
J Immunol; 1987 Jul; 139(2):551-6. PubMed ID: 3496384
[TBL] [Abstract][Full Text] [Related]
54. Recombinant interleukin-2-activated intracavitary lymphocytes: phenotypic characteristics and effector function.
Umiel T; Monselise J; Klein T; Rakovsky E; Fenig E; Lurie H; Adler A
J Biol Response Mod; 1989 Aug; 8(4):409-21. PubMed ID: 2787838
[TBL] [Abstract][Full Text] [Related]
55. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
Galandrini R; Albi N; Zarcone D; Grossi CE; Velardi A
Eur J Immunol; 1992 Aug; 22(8):2047-53. PubMed ID: 1379184
[TBL] [Abstract][Full Text] [Related]
56. CD3+4-8-WT31-(T cell receptor gamma+) cells and other unusual phenotypes are frequently detected among spontaneously interleukin 2-responsive T lymphocytes present in the joint fluid in juvenile rheumatoid arthritis. A clonal analysis.
De Maria A; Malnati M; Moretta A; Pende D; Bottino C; Casorati G; Cottafava F; Melioli G; Mingari MC; Migone N
Eur J Immunol; 1987 Dec; 17(12):1815-9. PubMed ID: 2961576
[TBL] [Abstract][Full Text] [Related]
57. Differences in the stimulating capacity of immobilized anti-CD3 monoclonal antibodies: variable dependence on interleukin-1 as a helper signal for T-cell activation.
Verwilghen J; Baroja ML; Van Vaeck F; Van Damme J; Ceuppens JL
Immunology; 1991 Feb; 72(2):269-76. PubMed ID: 1826671
[TBL] [Abstract][Full Text] [Related]
58. Tumor cytolysis by lymphocytes infiltrating ovarian malignant ascites.
Ioannides CG; Platsoucas CD; Rashed S; Wharton JT; Edwards CL; Freedman RS
Cancer Res; 1991 Aug; 51(16):4257-65. PubMed ID: 1868446
[TBL] [Abstract][Full Text] [Related]
59. Monoclonal antibodies against leucoagglutinin-reactive human T-lymphocyte surface components. II. Studies on the mechanism of K46M-induced activation and determination of the frequency of responding cells.
Berzins T; Vargas-Cortes M; Hammarström ML; Larsson A; Aguilar-Santelises M; Andersson G; Hammarström S; Perlmann P
Scand J Immunol; 1988 Dec; 28(6):773-82. PubMed ID: 3266027
[TBL] [Abstract][Full Text] [Related]
60. OKT3 monoclonal antibody inhibits cytotoxic T lymphocyte mediated cell lysis.
Chang TW; Gingras SP
Int J Immunopharmacol; 1981; 3(3):183-6. PubMed ID: 6457003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
